Results 261 to 270 of about 75,755 (323)

Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection

, 2010
Ramaswami Nalini, Kerem Özer, Mario Maldonado, Sanjeet Patel, Christiane S. Hampe, Anu Guthikonda, Jesus A. Villanueva, E. O’Brian Smith, Lakshmi K. Gaur, Ashok Balasubramanyam   +9 more
openalex   +2 more sources

Association of Serum Vitamin D With Macular Microvascular Structure in Type 2 Diabetic Mellitus Without Diabetic Retinopathy: A Cross‐Sectional Study

Journal of Diabetes Research, Volume 2026, Issue 1, 2026.
Purpose This study investigated the association of different serum vitamin D levels on macular microvascular structure in Type 2 diabetes mellitus (T2DM) patients without diabetic retinopathy (DR), utilizing optical coherence tomography angiography (OCTA).
Hui Yang, Xinyan Ma, Youjin Pan, Suilian Zheng, Haihua Zheng, Zheren Xia, Hannah Wesley   +6 more
wiley   +1 more source

Severe Adverse Effects of Tirzepatide Overdose Requiring Intensive Care Unit Admission and Complex Rehabilitation. [PDF]

Cureus
Sharafeldin M, Alhamdan N, Khaliq A.
europepmc   +1 more source

Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta‐Analysis of Comparative Studies

Journal of Diabetes Research, Volume 2026, Issue 1, 2026.
Background Solid organ transplant recipients with diabetes mellitus face unique challenges in glycemic control, compounded by the metabolic effects of immunosuppressants. Although sodium–glucose cotransporter 2 (SGLT2) inhibitors are effective in diabetes, evidence for their use in transplant recipients remains limited.
Min Jung Geum, Kyung Sun Oh, Young-Mi Ah, Eusebio Chiefari   +3 more
wiley   +1 more source

Risk of Euglycemic Diabetic Ketoacidosis Can Persist After Discontinuation of Sodium-glucose Cotransporter-2 Inhibitors. [PDF]

JCEM Case Rep
Bobba SS, Campbell E, Bril F.
europepmc   +1 more source

From Pathophysiology to Treatment: Contemporary Approaches to CFRD in the Pediatric and Adolescent Population

Pediatric Diabetes, Volume 2026, Issue 1, 2026.
Cystic fibrosis‐related diabetes (CFRD) is the most prevalent nonrespiratory complication of cystic fibrosis (CF), with its prominence growing as survival rates improve due to advances in CFTR modulator therapies. Its prevalence increases with age, affecting nearly 50% of patients with CF (PwCF) over 30 years old.
Dogus Vuralli, Andrea Scaramuzza
wiley   +1 more source

Is Beta Ketothiolase Deficiency an Uncommon Disease or an Unsuspected Diagnosis? The Role of Genetic Biochemistry Approaches in Metabolic Acidosis. [PDF]

Pediatr Rep
Campos-Acevedo LD, Arenas-Estala J, Ibarra-Ramírez M, López-Uriarte GA, Ruíz-Herrera MC, Rodríguez-Rivera M, Martínez-de-Villarreal LE.   +6 more
europepmc   +1 more source

A Comparative Analysis of Diabetic Ketoacidosis (DKA) in Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Users Versus Non-users: A Systematic Review. [PDF]

Cureus
Abdella Altom SA, Alhajri AHM, Ali HKM, Mohammed Ahmed DA, Rabah Rahma MA, Mohamed Ahmed TA, Mohmmed Abd Alatif MM, Hassan Ahmed RA.   +7 more
europepmc   +1 more source

Coexistence of Maturity-Onset Diabetes of the Young Type 3 (MODY 3) and Diabetic Ketoacidosis: A Report of a Rare Case. [PDF]

Cureus
Ekwueme DE, Sann K, Rahman MM.
europepmc   +1 more source

Gas-forming Pyogenic Liver Abscess Mimicking Gastric Perforation in a Patient With Diabetic Ketoacidosis and Subsequent Rupture: A Case Report. [PDF]

Gastro Hep Adv
Sato T, Yamada K, Nishio A, Tokuda Y, Yamanaka C, Oka K, Morita K, Tarumi C, Hazu K, Nishiura Y, Higashihara K, Nagahama S, Matsumae T, Kegasawa T, Ishimi A, Hiyama S, Yamamoto K, Tatsumi N, Morimoto O, Kaneko A.   +19 more
europepmc   +1 more source